A new cleaning product that has been developed, could “significantly reduce” the rates of the hospital superbug Clostridium difficile, say researchers.
A study found that the product, Byotrol, led to a reduced presence of the infection C diff, in the wards where it was tried out.
In the areas cleaned with Byotrol, C diff was present in 20.4% of the sites tested, compared to 27.8% of the sites cleaned with traditional products.
According to the research, the number of patients who developed diarrhoea due to the potentially fatal bug was 50% lower in the wards cleaned with the new product.
The study was run in four hospital wards within the Manchester Royal Infirmary. Two of the wards were cleaned using Byotrol and the other two with bleach.
Dr Richard Deed said: ‘These results show that it is possible to drive significant reductions in one of the most persistent and challenging micro-organisms found within the healthcare system.’
Byotrol, which is cost comparable to most other day-to-day cleaners being used in wards, was made available to hospitals on the NHS supply chain in November.